Shinn, J.; Lee, J.; Lee, S.A.; Lee, S.J.; Choi, A.H.; Kim, J.S.; Kim, S.J.; Kim, H.J.; Lee, C.; Kim, Y.;
et al. Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease. Pharmaceutics 2022, 14, 1969.
https://doi.org/10.3390/pharmaceutics14091969
AMA Style
Shinn J, Lee J, Lee SA, Lee SJ, Choi AH, Kim JS, Kim SJ, Kim HJ, Lee C, Kim Y,
et al. Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease. Pharmaceutics. 2022; 14(9):1969.
https://doi.org/10.3390/pharmaceutics14091969
Chicago/Turabian Style
Shinn, Jongyoon, Juyeon Lee, Seon Ah Lee, Seon Ju Lee, Ah Hyun Choi, Jung Seo Kim, Su Jin Kim, Hyo Jin Kim, Cherin Lee, Yejin Kim,
and et al. 2022. "Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease" Pharmaceutics 14, no. 9: 1969.
https://doi.org/10.3390/pharmaceutics14091969
APA Style
Shinn, J., Lee, J., Lee, S. A., Lee, S. J., Choi, A. H., Kim, J. S., Kim, S. J., Kim, H. J., Lee, C., Kim, Y., Kim, J., Choi, J., Jung, B., Kim, T., Nam, H., Kim, H., & Lee, Y.
(2022). Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease. Pharmaceutics, 14(9), 1969.
https://doi.org/10.3390/pharmaceutics14091969